RSS

ischaemic stroke

In order to reduce the high level of disabilities and stroke recurrence in cases of acute ischaemic stroke (AIS) it is vital that the diverse unmet needs are addressed, according to data and analytics company, GlobalData. more

Analysis

An increase in clopidogrel prescriptions could be seen in the US and Europe for secondary ischaemic stroke prevention as a result of the outcomes of the Phase III POINT trial, according to data and analytics company, GlobalData. more

Analysis

Research from various academic institutions around London has revealed that anticoagulants may increase the risk of stroke in over-65s if they have chronic kidney disease. more

News

Evgen Pharma, a clinical-stage drug development company, has announced its collaboration with King’s College London to advance its lead product candidate as a therapy for ischaemic stroke. more

News